+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 35Years - 65Years
All Genders
ID06093932

Randomized Trial of Songling Xuemaikang Capsules for Treating Grade 1 Essential Hypertension in Adults Aged 35 to 65

Led by Xiyuan Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-08-20

100

Participants Needed

5

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of Songling Xuemaikang Capsules SLXMKC on adults aged 35 to 65 with grade 1 essential hypertension. The study aims to evaluate how well SLXMKC works, its impact on blood vessel function and structure, and to explore how it may help manage this level of high blood pressure. This is a randomized, double-blind, placebo-controlled trial sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences. Participants are randomly assigned to one of two groups for 12 weeks. One group receives therapeutic lifestyle changes for hypertension plus SLXMKC capsules taken three times daily, while the other group receives the same lifestyle changes plus placebo capsules on the same schedule. Both groups follow lifestyle interventions every day during the study period. During the trial, participants will have their blood pressure and vascular health monitored at the start, 4 weeks, and 12 weeks. Assessments include 24-hour blood pressure measurements, vascular stiffness tests, skin capillary density, and other blood pressure-related indicators. Researchers will also track symptoms, mental health scores, and any progression to more severe hypertension or organ damage. Safety and treatment adherence will be closely monitored throughout the study, which is scheduled to end in December 2027.

CONDITIONS

Brief Title

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

Research Team

A

Anlu Wang, Doctor

Q

Qiyu Liu, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here